Concepedia

Michael Heider

MH

Statistics

Publications

9

Citations

482

H-Index

9

Active since

2016

Affiliations

Technical University of Munich(Current)

Heidelberg University

TUM Klinikum

Charité - Universitätsmedizin Berlin

Ludwig-Maximilians-Universität München

Michael Heider is an author at Technical University of Munich specializing in molecular oncology, oncology, and molecular biology.

ORCID

Publications per year

2016–2025

9

Publications

9

Immunomodulatory drugs disrupt the cereblon–CD147–MCT1 axis to exert antitumor activity and teratogenicity

Ruth Eichner, Michael Heider, Vanesa Fernández‐Sáiz et al. · Nature Medicine · 2016 · 184 citations

, , +6

Stress response silencing by an E3 ligase mutated in neurodegeneration

Diane L. Haakonsen, Michael Heider, Andrew J. Ingersoll et al. · Nature · 2024 · 103 citations · Full text

, , +17

The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma

Michael Heider, Ruth Eichner, Jacob Stroh et al. · Molecular Cell · 2021 · 62 citations · Full text

, , +17

SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma

Guus J.J.E. Heynen, Francis Baumgartner, Michael Heider et al. · Blood Advances · 2022 · 31 citations · Full text

, , +13

A hybrid analytical-numerical method based on Isogeometric Analysis for determination of time varying gear mesh stiffness

A. Beinstingel, Michael W. Keller, Michael Heider et al. · Mechanism and Machine Theory · 2021 · 29 citations

, , +13

1–5 of 9